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When conventional stimulation protocol in IVF cycle fails to produce mature oocytes, many a times, the cycle is cancelled and 
the patient is disappointed.  Now that in-vitro maturation of oocyte is possible in view of commercial availability of media, 
perhaps it may be mandatory to retrieve immature oocytes and mature them in-vitro, freeze them if necessary and fertilize, 
develop embryos for transfer in order to help couples to achieve pregnancy.  Thus maturation in-vitro of GVs has become 
an important adjuvant for treating PCOS and in particular poor responders to gonadotrophin stimulation.  Our study is 
interesting because in spite of conventional stimulation protocol, we failed to recover any mature oocytes in eleven women 
when the average follicles size being 17mm at the time of hCG.  However, maturing these oocytes in-vitro, as a rescue 
measure, resulted in 50% of these women becoming pregnant after embryo transfer. 
 




     In vitro maturation is a practice of intentionally retrieving 
immature oocytes from small antral follicles and maturing them in 
vitro.  It has potential to substitute or at least adds as an adjuvant to 
standard IVF protocols.  IVM also reduces the time cost and 
inconvenience related to gonadotropin stimulation and almost 
eliminates the risk of OHSS (1) 
     Various Indications of IVM are PCOS, threatened OHSS, poor 
response to gonadotrophins and fertility preservation in cancer 
patients but interestingly it can be used as rescue measure in 
conventional IVF stimulation by maturing retrieved GVs in-vitro which 
is termed as “rescue IVM” (2,3). 
     Very often in IVF cycle protocol, a mixed cohort of matured 
oocytes (MII), MI, and post mature along with GVs are obtained (4).  
Competence of these immature oocytes retrieved is being 
questioned several times (5). The aim of the present study was to 
investigate the role of IVM of oocytes as a rescue measure in IVF 
cycles, when they produce only immature oocytes in spite of 
stimulation with gonadotrophins. 
 
MATERIALS AND METHODS 
 
     From March 2004 to September 2010, eleven women who 
underwent conventional IVF stimulation failed to produce any mature 
oocytes; but only GV stage oocytes were retrieved. Seven women 
who were between 23-39 years of age (average age 28.6 years), 
underwent down-regulation stimulation protocol while four were 
directly stimulated with recombinant FSH (rFSH).  When atleast 
three follicles reached 17mm in diameter, 10,000 IU hCG (Profasi)  
was administered and 34 – 36 later oocyte pick up was scheduled.  
Average E2 was 2107.g on the day of hCG which ranged between 
531 – 6950 in these women.  A total of 108 GV stage oocytes were 
obtained from eleven women. Immature oocytes were incubated in 
IVM media and checked for maturity periodically between 12 to 48 
hours. Only oocytes with 1st polar body extrusion were considered as 
mature and taken for ICSI. Fertilization was assessed 16 -18 hrs 
after ICSI .Cleavage stage embryos were transferred on day 2 after 
partial laser assisted hatching of the zona (6). 
     Luteal phase support was by vaginal insertion of micronized 
progesterone pessary, 300mg twice a day starting from the day of 
ICSI and continued till 12th week of pregnancy. Serum βhcg was 




     A total of 108 GVs were obtained from eleven patients with an 
average of 9.81 GVs per patient of which 72.22% oocytes matured 
in-vitro with fertilization rate of 75.64% and cleavage rate of  
94.91 %. Average number of embryos available was 5.09 per patient.  
Embryos were transferred in ten cases (90.9%) in the same cycle.  
In one case, only 3 GV stage oocytes were retrieved and none of 
them matured in-vitro.  Average number of embryos transferred per 
patient was 2.63 and 36.36% patients had extra embryos to freeze 
(See Table 1). 
     Out of ten patients who had fresh embryo transfer, five 
pregnancies were achieved with a pregnancy rate of 50% per ET.  
One patient was pregnant with frozen embryo transfer. Thus a total 
of six pregnancies achieved among eleven cases with augmented 
pregnancy rate of 50.46% per patient.  Out of six pregnancies, four 
resulted in full-term singleton live-births, one triplet pregnancy which 
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was reduced to twins by foetal reduction, unfortunately aborted at 17 
wks; one missed abortion at six weeks and the same woman came 
for frozen embryo transfer after 3 months, became pregnanct and 
delivered a full-term singleton baby.   Take home baby rate 
(THBR) was 36.36% (4/11).  No significant anamolies were seen at 
birth among the babies delivered.
 
Table 1. Clinical and laboratory outcome of rescue in vitro maturation 
 
  % 
No of patients  11*  
Average Age 28.6 yrs  
Average no of GVs / Pt 9.81  
Maturation rate 78/108 72.22% 
Fertilization rate 59/78 75.64% 
Cleavage rate 56/59 94.91% 
Average no of embryos/pt 5.09  
Av no of embryos transferred / Pt 2.63  
ET done 10/11 90.9% 
Extra embryos to freeze / Pt. 2.45                            
Pregnancy rate / ET 5/10 50% 
Pregnancy rate / Pt. 5/11 45.5% 
Clinical pregnancy rate / ET 5/10 50% 
Augmented pregnancy rate / Pt 6/11 50.46% 
THBR 4/11 36.36% 





     In 1994, Trounsen et al. (7), first reported a successful 
pregnancy following in vitro maturation of oocytes collected by 
transvaginal ultrasound guided aspiration of small follicles from 
unstimulated ovary in a   PCO patient.  Since then IVM has been 
used intentionally for PCOS, threatened OHSS and poor responders.  
Interestingly, it can also be used to rescue immature oocytes in IVF 
cycle when conventional protocol fails to produce mature oocytes, in 
spite of the average number of follicles reaching 17mm in diameter.  
The exact etiology of retrieving only GVs are not known. However, 
there are some studies which describe about intrinsic factors which 
may be responsible for maturation failure (8). 
     Most of the studies have discussed about intentional IVM for 
different indications (9). Our study of eleven patients suggests that 
immature oocytes obtained from large follicles can be matured in 
vitro, fertilized and good cleaving embryos could result in pregnancy.  
Our maturation rate was 72.22%, fertilization rate 75.44%, cleavage 
rate 94.91%, which seems that the oocytes were competent enough 
to produce clinical pregnancy rate of 50% and live birth of 36.36%.  
In our experience, clinical pregnancy rate and THBR are almost 
equal to the conventional IVF cycles. Most of the studies have shown 
that, in IVM, pregnancy rates are lower and abortion rates are higher 
than IVF cycles (10).  In our study average age of the patients were 
28.63 years, which may be a contributing factor for better success 
rate. Although the causes of maturation failure are multiple 
(11,12,13), we have been able to overcome by in vitro maturation, 
fertilization and establishing pregnancies resulting in four live births 
post ET.  However, the number of cases are too small to arrive at 




     Intentional IVM is a promising technology which can reduce 
the cost, cancellations, time consumed and inconvenience to the 
patients. Rescue IVM is an added important tool in ART which can 
result into viable pregnancies resulting in live births. Hence ART 
practice should include IVM technology to help couples to overcome 
cancellations and disappointment.   
 
REFERENCES  
[1] Marcus W. Jurema and Daniela Nogueira.  2006. In vitro 
maturation of human oocytes for assisted reproduction.  Fertil 
Steril, 86: 1277 – 1291. 
[2] Jun-Zhao Zhao, Wei Zhou, B.M., Wei Zhang, Hong-Shan Ge, 
Xue-Feng Huang, and Jin-Ju Lin. 2009. In vitro maturation and 
fertilization of oocytes from unstimulated ovaries in infertile 
women with polycystic ovary syndrome.  Fertil Steril, 
91:2568–71 
[3] Anne-Maria Suikkari. 2009.  Use of IVM in a clinical setting 
Book of Assisted Reproductive Technologies.  3rd Edition. 
Chapter 10: 155 – 162. 
[4] Smitz J and Cortvrindt R.1999.  Oocyte in‐vitro maturation and 
follicle culture: current clinical achievements and future 
directions. Hum Reprod.14 Suppl 1: 145–161. 
[5] D. Strassburger, S. Friedler, A. Raziel, E. Kasterstein, M. 
Schachter and R.Ron-El. 2004. The outcome of ICSI of 
immature MI oocytes and rescued in vitro matured MII 
oocytes.  Hum Reprod,19: 1587 – 1599. 
[6] Mantoudis E, Podsiadly BT, Gorgy A, Venkat G, Craft IL. 2001.A 
comparison between quarter, partial and total laser assisted 
hatching in selected infertility patients. Hum Reprod, 16:2182-
2186. 
[7] Trounson A, Wood C, Kausche A. 1994. In vitro maturation and 
the fertilization and developmental competence of oocytes 
recovered from untreated polycystic ovarian patients.  Fertil 
Steril. 62: 353 – 362.   
[8] Stephanie Beall, Carol Brenner, and James Segars. 2010.  
Oocyte maturation failure: a syndrome of bad eggs.  Fertil 
Steril, 94:2507–13. 
[9] Junko Otsuki, Yoshie Momma, Keiko Takahashi, Sachie 
Miyakura, Yasushi Nagai.  Timed IVM followed by ICSI in a 
Sulochana Gunasheela et al.,   
 
16
patient with immature ovarian oocytes.  Reprod BioMed 
Online, 13: 101 – 113. 
[10] Cha K.Y., Chung H.M, Lee D.R., et al 2005.. Obstetric outcome 
of patients with polycystic ovary syndrome treated by in vitro 
maturation and in vitro fertilization-embryo transfer.  Fertil 
Steril. 83(5):1461–1465.  
[11] Plachot M, Mayenga JM, Mandelboum J and Antoine JM .1998. 
Chromosome analysis of oocytes matured in‐vitro. Hum 
Reprod 13 (Abstract book 1),P‐1160. 
[12] Racowsky C and Kaufman ML.1992. Nuclear degeneration and 
meiotic aberrations observed in human oocytes matured 
in‐vitro: analysis by light microscopy. Fertil Steril 58,750–755. 
[13] Roberts R, Franks S and Hardy K .2002. Culture environment 
modulates maturation and metabolism of human oocytes. Hum 
Reprod 17,2950–2956.
 
 
